Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM

Contributed by: GlobeNewswire

Tags

Vironova BioAnalytics

More Like This

QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency

Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems

PR Newswire associated0

Averna Announces the Acquisition of Automated Test Solutions Provider ELCOM, a. s.

PR Newswire associated0

Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control

PR Newswire associated0

Averna Expands its Asian and North American Footprint with the Acquisition of Global Equipment Services, Inc. from Kimball Electronics, Inc.

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for clinical, industrial and research applications (Graphic: Sequentia Biotech)

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications

Immunovia Publishes Interim Report for January-June 2024

Immunovia Publishes Interim Report for January-September 2023